SARS CoV 2 News and Research

RSS

Designing hybrid antibodies with enhanced mobility and signaling capacity

Antibodies are the body's superheroes, recognizing and eliminating disease-causing substances.

25 Jun 2024

Study reveals early immune responses to SARS-CoV-2, offering insights for future COVID-19 treatments

Researchers analyzed early immune responses to SARS-CoV-2 using single-cell multi-omics, revealing key cellular states associated with different infection outcomes.

24 Jun 2024

Low-cost CRISPR-based paper strip test offers rapid influenza diagnosis

Fewer than one percent of people who get the flu every year get tested, in part because most tests require trained personnel and expensive equipment.

21 Jun 2024

Unveiling the role of auto-antibodies in COVID-19 severity

Even though COVID-19 manifests as a mild and short-lived disease in most people, some suffer extremely severe symptoms; in the worst cases, these patients die due to complications such as respiratory failure or thromboembolism.

19 Jun 2024

New research uncovers how some individuals avoid COVID-19 infection

Scientists have discovered novel immune responses that help explain how some individuals avoid getting COVID-19.

19 Jun 2024

Study shows vaccines cut long COVID risk, especially for those with preexisting conditions

A study in JAMA Network Open found that women and individuals with preexisting cardiovascular conditions are more likely to suffer from long COVID, but vaccinations, especially multiple doses, significantly reduce this risk.

18 Jun 2024

Drug-related infant deaths surge in the U.S., study finds

A recent study from the Journal of Perinatal Medicine reveals a significant rise in drug-related infant deaths in the U.S. between 2018 and 2022, highlighting the urgent need for targeted interventions.

18 Jun 2024

COVID-19 vaccines reduce infection and complications in pregnant women

The reactogenicity and impact of coronavirus disease 2019 (COVID-19) vaccines on pregnancy outcomes.

18 Jun 2024

New research on long COVID prevalence and risk factors

Early in the pandemic, many people who had SARS-Cov-2 infection or COVID-19 began to report that they couldn't shake off their symptoms even after a month or more - unusually long for a viral infection of the upper respiratory tract - or developed new, persistent symptoms soon after the infection cleared.

18 Jun 2024

At-home antibody tests could drive higher COVID-19 booster rates, new research finds

The feasibility and benefits of lateral flow assay (LFA)-based antibody tests for detecting inadequate COVID-19 immunity.

17 Jun 2024

Antenatal COVID-19 vaccination shown to be safe for pregnant women and their babies

A study in Obstetrics & Gynecology finds that antenatal COVID-19 vaccination does not increase the risk of adverse pregnancy outcomes, confirming vaccine safety for pregnant women.

12 Jun 2024

Study finds short-term side effects of COVID-19 mRNA vaccines boost long-term antibody response

Short-term adverse effects of COVID-19 mRNA vaccinations are linked to higher and longer-lasting neutralizing antibody responses, indicating robust immune efficacy.

11 Jun 2024

Attenuated virus helps eliminate cancer in mice

Northwestern Medicine scientists have discovered that an attenuated (weakened) virus can help eliminate cancer in mice.

11 Jun 2024

Sperm counts may not be declining globally, study suggests

The widely held view that sperm counts in men are dropping around the world may be wrong, according to a new study by University of Manchester, Queen’s University in Kingston, Canada and Cryos International, Denmark.

8 Jun 2024

Stanford study finds 15-day paxlovid treatment safe but ineffective for long COVID

In a clinical trial conducted by Stanford Medicine investigators and their colleagues, a 15-day course of Paxlovid - an antiviral drug combination targeting SARS-CoV-2, the virus that causes COVID-19 - proved safe as an extended-duration treatment but didn't lessen select symptoms of the syndrome known as long COVID: the persistence, or reappearance, of COVID-related symptoms three months or more after an initial COVID-19 infection.

7 Jun 2024

Innovative therapeutic strategies for combating type 2 diabetes

One of the most confusing aspects for patients with type 2 diabetes mellitus is that they have high fasting glucose levels.

7 Jun 2024

Three-year analysis of COVID-19's impact reveals persistent excess mortality in the Western world

Excess death rates have remained high in the West for three years running since the start of the COVID-19 pandemic, finds a data analysis of 47 countries published in the open access journal BMJ Public Health.

5 Jun 2024

Fertility warning: SARS-CoV-2 can linger in sperm for months after infection

Researchers at the University of São Paulo (USP) in Brazil have shown for the first time that SARS-CoV-2, the virus that causes COVID-19, can remain in the sperm of patients for up to 90 days after hospital discharge and up to 110 days after the initial infection, reducing semen quality.

4 Jun 2024

Novel small molecule oral antiviral could be a game-changer in the fight against future pandemics

Obeldesivir (GS-5245), a novel investigational small molecule oral antiviral, represents a new tool in the ongoing effort to prepare for future pandemics.

4 Jun 2024

Long COVID linked to higher risk of erectile dysfunction, new study finds

The risk of developing erectile dysfunction (ED) following a diagnosis of long coronavirus disease (COVID) compared to acute COVID.

4 Jun 2024

SARS CoV 2 News and Research

Designing hybrid antibodies with enhanced mobility and signaling capacity

Study reveals early immune responses to SARS-CoV-2, offering insights for future COVID-19 treatments

Low-cost CRISPR-based paper strip test offers rapid influenza diagnosis

Unveiling the role of auto-antibodies in COVID-19 severity

New research uncovers how some individuals avoid COVID-19 infection

Study shows vaccines cut long COVID risk, especially for those with preexisting conditions

Drug-related infant deaths surge in the U.S., study finds

COVID-19 vaccines reduce infection and complications in pregnant women

New research on long COVID prevalence and risk factors

At-home antibody tests could drive higher COVID-19 booster rates, new research finds

Antenatal COVID-19 vaccination shown to be safe for pregnant women and their babies

Study finds short-term side effects of COVID-19 mRNA vaccines boost long-term antibody response

Attenuated virus helps eliminate cancer in mice

Sperm counts may not be declining globally, study suggests

Stanford study finds 15-day paxlovid treatment safe but ineffective for long COVID

Innovative therapeutic strategies for combating type 2 diabetes

Three-year analysis of COVID-19's impact reveals persistent excess mortality in the Western world

Fertility warning: SARS-CoV-2 can linger in sperm for months after infection

Novel small molecule oral antiviral could be a game-changer in the fight against future pandemics

Long COVID linked to higher risk of erectile dysfunction, new study finds

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News